Replies to post #59794 on PharmaCyte Biotech Inc (PMCB)

[ace1234]

I can start by saying we have world renown oncologists on the team here at PMCB including Dr. Daniel Von Hoff who is considered the world's leading expert on pancreatic cancer.

He has taken many drugs through the FDA approval process. That alone should tell you a lot of things.

New management has assembled a consortium of oncologists like Von Hoff to bring CIAB to the market.

They've taken care of CGMP certification for facilities in Thailand to be able to manufacture CIAB.

Now they've gotten us to the door of the FDA.

Management is well experienced. I'm sure you'll find that out once you check them out for yourself. A lot of other members here could link you to some good information.

Everything on the intro to this board is nice starting point if you haven't skimmed over it yet.

[ace1234]

If you really want you can read the book by Dr. Brandtner who co-developed the cells. Her name is on the patents to this technology.

http://ebooks.benthamscience.com/book/9781608057207/

[ace1234]

However keep in mind, that while this technology is extremely promising, there are competitors out there with similar technology.

A company called ViaCyte... eerily/strangely similar to PharmaCyte is already in clinicals for type 1 and type 2 diabetes using cell encapsulation. They had their IND meeting in 2014 and are currently in phase 1/2.

Management is currently focusing on pancreatic cancer because there is an urgent unmet need. Considering that we have the best of the best on board, I would say PMCB has a high likelihood of fulfilling that need.

Once that is out of the way, diabetes will sure follow, but it's hard to say if another encapsulation technology will have already entered the market.

I know when you look at a stock you have to think rationally. There is always risk involved... and competition, but I believe PMCB has got what it takes.